+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5893149
Description Jump to:
The global research-grade proteins market size is anticipated to reach USD 1.75 billion by 2030. The market is projected to grow at a CAGR of 11.49% from 2025 to 2030. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.’s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.61% in 2024 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2024. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.48% in 2024. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.47% in 2024. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Host Cell Segment
1.2.3. End Use Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
Chapter 2. Research-grade Proteins Market: Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Increasing use of recombinant proteins in research activities
3.3.1.2. Growing research activities for drug discovery and precision medicine
3.3.1.3. Rising adoption of biologics & biosimilars
3.3.2. Market Restraint Analysis
3.3.2.1. Regulatory and safety concerns regarding protein production
3.3.2.2. Dearth of skilled personnel and expertise
3.4. Business Environment Analysis
3.4.1. PESTEL Analysis
3.4.2. Porter’s Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Research-grade Proteins Market: Product Movement Analysis
4.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Cytokines & Growth Factors
4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
4.4.2. Interferons (IFNs)
4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
4.4.3. Interleukins (ILs)
4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others Market, 2018 - 2030 (USD Million)
4.5. Antibodies
4.5.1. Antibodies, 2018 - 2030 (USD Million)
4.6. Immune Checkpoint Proteins
4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
4.7. Virus Antigens
4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
4.8. Enzymes
4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
4.8.2. Kinases
4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
4.8.3. Metabolic Enzymes
4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
4.8.4. Others
4.8.4.1. Others Market, 2018 - 2030 (USD Million)
4.9. Recombinant Regulatory Proteins
4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
4.10. Hormones
4.10.1. Hormones Market, 2018 - 2030 (USD Million)
4.11. Others
4.11.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Host Cell Business Analysis
5.1. Host Cell Segment Dashboard
5.2. Research-grade Proteins Market: Host Cell Movement Analysis
5.3. Global Research-Grade Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
5.4. Mammalian Cells
5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
5.5. Bacterial Cells
5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
5.6. Yeast & Fungi
5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
5.7. Insect Cells
5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Research-grade Proteins Market: End Use Movement Analysis
6.3. Global Research-Grade Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.4. Spain
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.5. France
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.6. Italy
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.7. Australia
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Abcam Plc
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Miltenyi Biotec
8.4.3.1. Company Overview
8.4.3.2. Product Benchmarking
8.4.3.3. Strategic Initiatives
8.4.4. GenScript
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Techne
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Proteintech Group, Inc.
8.4.6.1. Company Overview
8.4.6.2. Product Benchmarking
8.4.6.3. Strategic Initiatives
8.4.7. ACROBiosystems
8.4.7.1. Company Overview
8.4.7.2. Product Benchmarking
8.4.7.3. Strategic Initiatives
8.4.8. Sino Biological, Inc.
8.4.8.1. Company Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. ProSpec-Tany TechnoGene Ltd.
8.4.9.1. Company Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. New England Biolabs
8.4.10.1. Company Overview
8.4.10.2. Product Benchmarking
8.4.10.3. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 6 North America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 9 U.S research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 12 Canada research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 13 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 15 Mexico research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 16 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 17 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 18 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 19 Europe research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 20 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 21 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 22 UK research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 24 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 25 Germany research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 26 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 27 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 28 France research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 29 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 30 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 31 Italy research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 32 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 33 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 34 Spain research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 35 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 37 Denmark research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 38 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 40 Sweden research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 41 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 42 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 43 Norway research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 44 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 47 Asia Pacific research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 48 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 49 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 50 China research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 52 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 53 Japan research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 54 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 55 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 56 India research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 57 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 58 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 59 South Korea research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 61 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 62 Australia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 63 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 64 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 65 Thailand research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 66 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 69 Latin America research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 70 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 72 Brazil research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 75 Argentina research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 82 South Africa research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 88 UAE research-grade proteins market, by end use, 2018 - 2030 (USD Million)
Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 91 Kuwait research-grade proteins market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global research-grade proteins market- Key market driver analysis
Fig. 7 Global research-grade proteins market - Key market restraint analysis
Fig. 8 Global research-grade proteins market - Porter’s analysis
Fig. 9 Global research-grade proteins market - PESTEL analysis
Fig. 10 Global research-grade proteins market: Product outlook key takeaways
Fig. 11 Global research-grade proteins market: Product movement analysis
Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
Fig. 27 Global research-grade proteins market: Host cells movement analysis
Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
Fig. 33 Global research-grade proteins market: End use outlook key takeaways
Fig. 34 Global research-grade proteins market: End use movement analysis
Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global research-grade proteins market: Regional movement analysis
Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 43 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 44 Europe research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 45 UK research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 46 Germany research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 47 France research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 48 Spain research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 49 Italy research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 50 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 51 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 52 Norway research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 54 Japan research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 55 China research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 56 India research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 57 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 58 Australia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 59 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 60 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 61 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 68 Strategy framework

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Danaher (Abcam Plc)
  • Miltenyi Biotec
  • GenScript
  • Bio-Techne
  • Proteintech Group, Inc.
  • ACROBiosystems
  • Sino Biological, Inc.
  • ProSpec-Tany TechnoGene Ltd.
  • New England Biolabs

Methodology

Loading
LOADING...

Related Topics

Related Reports

Research-Grade Proteins Global Market Report 2024 - Product Image

Research-Grade Proteins Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032 - Product Image

Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032

  • Report
  • 150 Pages
  • Global
From
Culture Media Cytokine Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Culture Media Cytokine Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cytokine Release Syndrome - Pipeline Insight, 2024 - Product Image

Cytokine Release Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Cytokine Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Cytokine Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 94 Pages
  • Global
From

About the Research Grade Proteins Market

The Research Grade Proteins market is a key component of the drug discovery process. Proteins are essential for understanding the structure and function of biological systems, and are used to develop new drugs and therapies. Research grade proteins are produced in a highly controlled environment, ensuring that they are of the highest quality and purity. They are used in a variety of applications, including drug screening, target identification, and biomarker discovery. Research grade proteins are used in a variety of drug discovery processes, including high-throughput screening, structure-based drug design, and protein-protein interaction studies. They are also used in the development of novel therapeutic agents, such as monoclonal antibodies and small molecule drugs. Companies in the Research Grade Proteins market include Abcam, Bio-Techne, Merck KGaA, Thermo Fisher Scientific, and GenScript. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.